What does this research mean for the field?

Distinct metabolomic signatures in fecal samples are associated with different phenotypes and disease activity in Crohn's Disease. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to identify metabolomic differences related to Crohn’s disease phenotypes and activity levels.

March 12, 2026Open Access

Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease

Key Points

The aim is to identify metabolomic differences related to Crohn’s disease phenotypes and activity levels.
Conducted metabolomic profiling of fecal samples
Analyzed differences based on disease phenotypes and activity
Assessed potential as noninvasive biomarkers for patient stratification
Identified distinct metabolomic signatures tied to disease phenotypes
Demonstrated variations in metabolomics correlated with disease activity
Highlighted potential for using metabolites as biomarkers for guiding management

Abstract

This study reveals metabolomic differences across CD phenotypes and disease activity, providing potential noninvasive biomarkers to help risk-stratify patients for complications and guide tailored management. Further validation in larger cohorts is warranted.

Bookmark

View Full Paper

Bookmark

View Full Paper

Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease

Key Points

Abstract

Cite This Study